Professional Documents
Culture Documents
Dear Doctor,
Essential drugs are those that satisfy the health care needs of the majority of the
population; they should therefore be available at all times in adequate amounts and in
the appropriate dosage forms, and at a price that individuals and the community can
afford.
Careful selection of a limited range of essential medicines results in a higher quality of care,
better management of medicines (including improved quality of prescribed medicines),
and more cost-effective use of health resources
(WHO Expert Committee on the Use of Essential Drugs, 1999).
Many states in India including Karnataka, Kerala, Himachal Pradesh, Delhi, Maharashtra and
Rajasthan have prepared their essential drug lists. The Government of Chhattisgarh also has taken
the initiative to prepare and adopt the Essential Drug List for Chhattisgarh (EDLC). The relevant
Government Orders are enclosed.
The Basic Goals of the ELD Chhattisgarh are:
To ensure the availability and accessibility of essential drugs to all citizens of
Chhattisgarh;
To ensure safety, efficacy and quality of drugs in the public health system;
To encourage and support good prescribing and dispensing practices;
The Process: The Department of Health & Family constituted a committee headed by the Director,
Medical Education with the Director Health Services and the Dean of the Medical College as
members to draw up theEDL Chhattisgarh. In turn, this committee, with the technical assistance of
the State Health Resource Centre, Chhattisgarh set up one day three intensive consultation with
senior medical professionals, the faculty of Raipur Medical College, NGOs active in the health field,
and senior departmental officials. The State Advisory Committee also gave valuable inputs to this
process. Experts in rational drug policy from other states were also invited to this consultation. The
W H O Model List for the year 2015, NELM of 2015, British National Formulary 2009 and National
Drug Formulary 2011 were used as the base papers for this discussion in finalising theEDL
Chhattisgarh.
The Criteria: The principal criteria for the selection of essential drugs for primary, secondary and
tertiary hospital care were based on the WHO guidelines for drawing up an EDL. They include the
following points:
Any drug included must meet the needs of the majority of the population;
Sufficient proven scientific data regarding effectiveness must be available;
Any drug included in the EDL should have substantial safety and benefit/ risk
ratio;
All products must be of acceptable quality, and must be tested on a continuous
basis;
The aim, as a rule, is to include, only products containing single
pharmacologically active ingredients;
Combination products, as an exception, will be included where patient
compliance becomes an important factor or where two pharmacologically active
ingredients are synergistically active in a product;
Products will be listed according to their generic names only;
Where drugs are clinically equally effective, the dugs will be compared on the
following factors:
Grading of the Essential Drug List: The EDL Chhattisgarh is published in two parts, first part consist
of list of drugs which are essentially required at primary, secondary and tertiary level of medical
facilities. Second part is drugs which are required at specialty centers and are prescribed by
specialists with extra attention. The main EDL Chhattisgarh covers the needs of all public health
facilities excepting the medical college. It is graded to indicate drugs that shall be supplied to all
health centers and those that are restricted to Primary, secondary and tertiary level medical
facilities.(which includes PHC, community health centers and District Hospitals).
Depending on the specialist and equipment available in each health care institution these facilities
would specify their drug requirements from within this list. The list of drugs for the Medical College
Hospital (tertiary care), was prepared by the faculty of the college and is published as a
supplementary list. Another supplementary list (Universal category) specifies the drugs that would
be made available to the multipurpose health workers both male and female. While grading the list
we have kept in mind the specific demands of Chhattisgarh given the distances and problems in
transport and the fact that referral to higher centers is not easy. The broad principle followed is to
provide as comprehensive a care as possible, made available as peripherally as possible - given
the human resource and infrastructure available at that level. All drug purchase made by the
Government of Chhattisgarh would have to comply with the EDL Chhattisgarh.
Amendment of EDL/ Adding a New Product on EDL Chhattisgarh: We recognize that a good drug
policy requires to EDL Chhattisgarh dynamic and updated periodically. We welcome suggestions
towards this. Requests for products to be included on the EDL Chhattisgarh must conform to the
above criteria and must be supported by evidence-based data and appropriate references on its
advantages and benefits over existing products. A format for such requests has been given as
been appended.
The Department of Health and Family Welfare will be appointing a Committee to monitor the
implementation of the EDL Chhattisgarh and make periodic revisions of the list. An essential drug
formulary, and a graded standard treatment protocol as well as mechanisms to train various
categories of staff and promote the use of the list would be in place soon. Other supporting systems
to ensure safe and adequate essential drug supply to every citizen of Chhattisgarh are in our plans.
I hereby express my sincere thanks to all those experts, the medical community of Chhattisgarh
and the concerned NGO representatives whose valid contributions paved way to the EDL
Chhattisgarh and its publication. I hope the medical community of the state will welcome and
nourish this move as this is the threshold point towards a comprehensive and rational drug policy
for the state.
Sincerely Yours,
Vikas Sheel
Secretary to Government of Chhattisgarh
Department of Health & Family Welfare.
Acknowledgements
Even small efforts raise large debts. For the finalisation of the Essential Drug List of
Chhattisgarh, we are indebted to a number of individuals and organisations. The committee
appointed by the Department of Health & Family Welfare led by the Dr Shashank Gupta,
HOD, Medicine JNMCH Medical College Hospital Raipur. Dr. S K Shandilya came up with
the idea of holding a workshop for finalizing the Essential Drug List and charting out the
broad contours of the State Drug Policy. Dr. A K Chandrakar, Dean, Jawaharlal Nehru
Memorial Medical College, Raipur not only made valuable contributions to the consultation
but also enthused the senior faculty of this primer institution to attend and contribute to the
deliberations in meetings. Director, Health Services, ensured the participation of his colleagues
and has supported this process since its inception.
The State Advisory Committee has helped in the broadening of the mandate of the changes
being undertaken in the health sector in Chhattisgarh and provided the much-needed
perspective for this effort.
Narayan Tripathi, Fidius Kerketta and Dr Prabir Chatterjee from State Health Resource
Centre undertook the logistics and co-ordination of the workshop and courteously
accommodated every demand made of them during and after the workshop.
Lastly, much of the efforts towards community basing of health services in Chhattisgarh
would not have been possible without the strong endorsement, conviction and belief of Dr
Ayyaz F Tamboli and Avinash Chamapavat IAS who were MD NHM when this work was in
progress.
R Prasanna
Director Health Services,
Department of Health & Family Welfare
ESSENTIAL DRUGS LIST PART I
CONTENTS
PART A
1. ANAESTHETICS
2. ANALGESICS, ANTIPYRETICS, NONSTEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIDS), MEDICINES
USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS USED IN RHEUMATOLD DISORDERS
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
5. ANTICONVULSANTS / ANTIEPILEPTICS
6. ANTI INFECTIVE DRUGS
7. ANTIMIGRAINE MEDICINES
8. ANTINEOPLASTIC IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
9. ANTIPARKINSONS MEDICINE
10. MEDICINES AFFECTING THE BLOOD
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
12. CARDIOVASCULAR MEDICINES
14. DERMATOLOGICAL MEDICINES (topical)
15. DIAGNOSTIC AGENTS (enlisted in section of Surgical and suture list)
16. PERITONEAL DIALYSIS SOLUTION restricted to tertiary care center where peritoneal dialysis is undertaken
17. DISINFECTANTS AND ANTISEPTICS
18. DIURETICS
19. EAR, NOSE AND THROAT PREPARATIONS
20. GASTROINTESTINAL MEDICINES
21. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
22. IMMUNOLOGICALS
23. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
24. SPECIFIC MEDICINES FOR NEONATAL CARE
25. OPHTHALMOLOGICAL PREPARATIONS
26. OXYTOCICS AND ANTIOXYTOCICS
27. PSYCHOTHERAPEUTIC MEDICINES
28. MEDICINES ACTING ON THE RESPIRATORY TRACT
29. SOLUTIONS CORRECTING WATER, ELECTROLYTE AND ACID-BASE DISTURBANCES
30. VITAMINS AND MINERALS
PART-B
SURGICAL, DIAGNOSTIC AGENTS AND SUTURE LIST
1. ABSORBABLE SUTURES
2. NON ABSORABLE SUTURES BLACK BRAIDED SILK
3. POLYGLECAPRON SUTURES
4. POLYDIOXANONE SUTURES
APPENDIX
1. Format to Amend the Essential Drug List for Chhattisgarh
2. Adverse Drug Reaction Reporting Form http://ipc.nic.in http://cdsco.nic.in/pharmacovigilance.htm
3. List of Participants
4. Universal Category List
5. Primary Category List
6. Secondary Category List
7. Specialist Category List
ESSENTIAL DRUG LIST -2016
1. ANAESTHETICS
1.1 General anaesthetics and oxygen
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Halothane Inhalation S 250ml Bottle D253
50 mg/ml in 2ml Vial S 2ml Vial D297
Ketamine hydrochloride Injection
50 mg/ml in 10ml 10ml Vial D298
Vial
Nitrous oxide Inhalation S Cylinder D372
Oxygen Inhalation P Cylinder D392
Thiopentone sodium Injection 0.5 g S 50 ampoules D503
1.0 g D504
Isoflurane Inhalation (Vaporiser) T 100 ml Bottle D286
Sevoflurane Inhalation (Vaporiser) T 250ml PEN Bottle D471
Propofol Injection 1% S 20ml vial D439
1.2 Local anaesthetics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bupivacaine hydrochloride Injection 0.25% in vial P 20ml Vial D80
0.5% in vial D81
Injection for Spinal 0.5% in 4-ml P 4ml Ampoule D82
Anaesthesia ampoule to be mixed
with 7.5% glucose
solution
Lidocaine hydrochloride Injection 1% P 30ml vial D307
2% 30ml vial D308
Injection for Spinal 5% to be mixed with 2ml ampoule D309
Anaesthesia 7.5% glucose
solution
Jelly (Topical) 2% S 30gm tube D310
Viscous Solution (Topical) 4% P 30ml D311
4.2 Specific
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atropine Sulphate Injection 0.6 mg/ml P 2ml ampoule D56
Calcium gluconate Injection 100 mg/ml P 10ml ampoule D84
Pralidoxime Injection 25mg/ml P 20ml Vial D426
Neostigmine Metilsulfate Injection 500 micrograms S 1ml ampoule D364
Disulfiram Tablet 250mg T D609
500mg T D610
Prazocin Tablet 1mg S D717
Tablet 2mg S D718
Deferasirox Injection 500mg T D602
Tablet 500mg T D603
5. ANTICONVULSANTS/ANTIEPILEPTICS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Carbamazepine Tablet (Control Release) 200 mg S 10 x 10 D86
400 mg 10 x 10 D87
500mg 10 x 10 D515
500 mg 10 x 10 D123
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Clofazimine Capsule 50 mg P D128
100 mg 10 x 10 D129
Dapsone Tablet 25 mg P 10 x 10 D147
50 mg 10 x 10 D148
100 mg 10 x 10 D149
Rifampicin Tablet or Capsule 150 mg P 10 x 10 D456
450 mg 10 x 10 D457
600 mg 10 x 10 D458
Ofloxacin Tablet 200mg T 10 x 10 D378
400mg 10 x 10 D379
6.2.4 Antituberculosis medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ethambutol Hydrochloride Tablet 400 mg P 10 x 10 D629
200 mg 10 x 10 D630
800 mg 10 x 10 D205
Isoniazid Tablet 100mg P 10 x 10 D287
300 mg 10 x 10 D288
Pyrazinamide Tablet 500 mg P 10 x 10 D445
750 mg 10 x 10 D446
Rifampicin Tablet or Capsule 150 mg P 10 x 10 D456
450 mg 10 x 10 D457
600 mg 10 x 10 D458
Streptomycin Sulphate Powder for Injection 1g P Vial D485
Cycloserine Tablet 250mg P 10 x 10 D596
Ethionamide Tablet 250mg S 10 x 10 D634
Kanamycin Tablet 500mg S 10 x 10 D673
1000mg 10 x 10 D674
Linezolid 300ml bottle 2mg/ml T ND16
Levofloxacin Tablet 500mg T(R) ND17
6.3 Antifungal medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Amphotericin B lipholised Powder for Injection 50 mg T Vial D38
Fluconazole Capsule 150 mg P Single dose pack/ 10 x D225
10
200 mg D226
Injection 2 mg/ml P Vial D227
Oral Suspension 50 mg/5-ml P D228
Nystatin Oral Solution 50mg/5ml (100000 T D376
IU/ml)
Lozenge 100000 IU D377
Povidone Iodine Vaginal Passaries 200mg S 10 passaries D425
Clotrimazole Ear Drops 1% W/V S 10ml D130
Clotrimazole S
Mouth Paint 1% W/V D131
Cream 2% W/W P 15gm tube D132
Benzoic acid compound Ointment (6%+ 3% ) T 15gm tube D67
(Benzoic acid + Salicylic acid)
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acyclovir Tablet 200 mg S 10 x 10 D6
Oral Solution 200mg/5ml 60ml bottle D7
Ophthalmic Ointment 0.03 5gm tube D9
Powder for Injection 250 mg 10ml Vial D10
Tablet 800mg 10x10 D559
6.4.2 Anti retrovirals Medicine
6.4.2.1 Nucleoside reverse transcriptase inhibitors-T ART (to be provided by NACO)
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Zidovudine Capsule 100 mg S 10 x 10 D536
250 mg 10 x 10 D537
Tablet 300 mg 10 x 10 D538
Oral Liquid 50 mg/5 ml 100ml bottle D539
IV or Infusion Injection 10mg/ml 20ml Vial D540
Stavudin+Lamuvidin Tablet 30mg+150mg T 10x10 D737
Zidovudine +Limuvidin+ Tablet 300mg+150mg+200 S 10x10 D762
Nevirapine mg
6.4.3 Other antivirals
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Oseltamivir Capsule 30 mg T 10 x 10 D388
Capsule 45 mg 10 x 10 D389
Capsule 75 mg 10 x10 D390
Syrup 100ml bottle 10x10 D707
Dry Powder for Oral 12 mg/ml 75ml bottle D391
Suspension
Nevirapine Tablet 200mg T 10 x 10 D363
Oral Suspension 50mg/5ml 100ml D364
Tablet (Yellow Colour) 2-4 year Combi pack for full D558
(AS:50mg,SP:500m course (3 days)
g+25mg)
Tablet(Green Colour) 5-8 year Combi pack for full D554
(AS:100mg,SP:750 course (3 days)
mg+37.5mg)
Tablet (Red Colour) 9-14 year Combi pack for full D556
(AS:150mg,SP:500 course (3 days)
mg+25mg)
Tablet (White Colour) 15 year & above Combi pack for full D557
(AS:100mg,SP:750 course (3 days)
mg+37.5mg)
Artether Injection 150mg P 2 ml x 3 D562
6.6. Insect repellant
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Diethyltoluamide Cutaneous Solution 0.5 P D176
0.75 D177
Synthetic pyrethroid WP As per NVBDCP U D496
Supply
DDT Powder As per NVBDCP U D151
Supply
Deltamethrin Solution 2.50% U D153
7. ANTIMIGRAINE MEDICINES
7.1 For acute attack
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetyl Salicylic Acid (ASA) Tablet (Enteric Coated) 325 mg P 10 x 10 D4
Paracetamol Tablet 500 mg P 10 x10 D395
Clonidine injection 150mg/ml T ND15
7.2 For prophylaxis
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Propranolol Tablet 10 mg S 10 x10 D440
40 mg 10 x 10 D441
8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bortezomib IP Injection 2 mg T(R) Vial D571
Carboplatin IP Injection 150 mg T(R) Vial D579
Carboplatin IP Injection 450mg T(R) Vial D580
Cisplatin Injection 10mg/10ml T(R) Vial D127
Cyclophosphamide Injection 200mg T(R) 30ml vial D144
Cyclophosphamide Injection 500mg T(R) Vial D595
Docitaxel IP Injection 20 mg with Solvent T(R) Vial D612
Docitaxel IP Injection 80 mg with Solvent T(R) Vial D613
Doxorubicin Injection 10mg/5ml T(R) 5ml Vial D191
Florouracil Injection 250mg T(R) 5ml ampoule D224
Hydroxyurea Capsule 500mg T(R) 10 x 10 D268
Methotrexate Tab./Injection 5mg T(R) 10 D685
Methotrexate Injection 10mg T(R) Vial D686
Methotrexate IP (preservative free) Injection 15 mg T(R) Vial D688
Erythropoietin IP Injection 10000 units T(R) Vial D624
Erythropoietin IP Injection 40000 units T(R) Vial D624A
Tamoxifen Injection 20mg T(R) Vial D742
Tamoxifen Injection 10mg T(R) Vial D742A
Oxaliplatin IP Injection 100 mg T(R) Vial D708
Oxaliplatin IP Injection 50 mg T(R) Vial D709
Bicalutamide Tablet 50 mg T(R) 10 D568
Bleomycin Injection 15mg T(R) Vial D79
Capecitabine Capsule 500 mg T(R) 10 D578
Chlorambucil Capsule 5mg T(R) 10 tablet packs/10 x 10D107
D actinomycin Injection 0.5mg T(R) Vial D146
Daunorubicin IP Injection 20 mg T(R) Vial D600
Etoposide Capsule 100mg T(R) 4cap. Pack/4cap.x 10 D213
Etoposide Injection 100mg/5ml T(R) 5ml Vial D214
Ifosphamide IP Injection 1gm T(R) Vial D666
L.Asparaginase IP Injection 10000 units T(R) Vial D678
Mercaptopurine Tablet 50mg T(R) 10 x 10 D332
Paclitaxel IP Injection 260 mg with solvent T(R) Vial D710
Procarbazine Capsule 50mg T(R) 10 x 10 D434
Rituximab Injection 10mg/ml T(R) Vial D729
Temozolomide Capsule 100mg T(R) 10 D745
Temozolomide Capsule 250mg T(R) 10 D746
Temozolomide Injection 20mg T(R) 10mg D747
Thalidomide Tablet 100 mg T(R) 10 D748
Trastuzumeb Injection 440 mg T(R) Vial D756
Vinblastine Injection 10mg T(R) Vial D522
Vincristine Injection 1 mg T(R) Vial D523
Cytarabine Injection 500mg T(R) 5ml Vial D145
Cytarabine Injection 100mg T(R) 5ml Vial
Granisetron IP Tablet 1mg T(R) 10 D656
Granisetron IP Injection 3mg T(R) Ampoule D657
Idarubicin IP Injection 10 mg T(R) Vial D665
Irinotecan IP Injection 100 mg T(R) Vial D671
Leucovarin IP Injection 50 mg T(R) Vial D682
Nenotaxel IP Injection 100 mg T(R) Vial D698
Nenotaxel IP Injection 300mg T(R) Vial D699
Pemetrixate IP Injection 500 mg T(R) Vial D712
Pemetrixate IP Injection 100mg T(R) Vial D713
Busulfan Capsule 2mg T(R) 10 x 10 D83
Dacarbazine Injection 200mg T(R) ND7
Dacarbazine Injection 400mg T(R)
Arsenic trioxide Injection 1mg/ml T(R) ND31
Calcium folinate Tab 15mg T(R) ND32
Calcium folinate Injection 3mg/ml T(R) ND32A
Mesna Injection 100mg/ml T(R) ND33
9. ANTIPARKINSONS MEDICINE
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Trihexyphenidyl Hydrochloride Tablet 2 mg S 10 x 10 D511
equivalent to 20 mg 10 x 10 D222
iron + 0.1mg folic
acid
Syrup equivalent to 20 mg U 10 x 10 D223
Iron + 0.1mg Folic
acid per 1ml in bottle
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Heparin Sodium Injection 1000 IU/ml S 1ml ampoule D254
5000 IU/ml 1ml ampoule D255
20000 IU/ml 1ml ampoule D256
Phytomenadione Injection 10 mg/ml S 5ml ampoule D410
Tablet 10 mg D411
Protamine Sulphate Injection 10 mg/ml S 5ml ampoule D444
Warfarin Sodium Tablet (Score) 1 mg S 10 x 10 D530
5 mg 10 x 10 D531
Vitamin K Injection 1mg/ml T 1ml ampoule D528
Vitamin K1 Injection 1mg/ml T (R) 1ml ampoule D529
Streptokinase Injection 15,00,000 IU T Vial D484
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
11.1 Plasma substitutes
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydroxyethyl Starch Injection 6% S 500ml D267
Tranexamic Acid Tablet 500mg T 10 x 10 D509
Injection 500mg/5ml 5ml ampoule D510
11.2 Plasma fractions for specific use T
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Albumin Injection 20% in 50ml T D14
20% in 100ml D15
Cryoprecipitate Injection T D142
Factor IX Complex Injection Dried T D215
(Coagulation factors II,VII,IX X)
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atenolol Tablet 50 mg P 14 x 10 D52
Digoxin Tablet 250 mcg S 10 x 10 D178
Oral Solution 50 mcg/ml 30ml D179
Injection 250 mcg/ml 2ml ampoule D180
Lidocaine Hydrochloride Injection 20 mg/ml S 5ml ampoule D312
(preservative free)
Verapamil Hydrochloride Tablet 40 mg T 10 x 10 D520
Injection 2.5 mg/ml S 2ml ampoule D521
Amiodarone Tablet 200mg T 10 x 10 D23
Injection 150mg 3ml vial D24
Diltiazem Tablet 30mg T 10 x 10 D181
Injection 30mg Vial D182
Adenosine Injection 3mg/ml T 2ml ampoule D11
12.3 Antihypertensive medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Atenolol Tablet 50 mg P 14 x 10 D52
25 mg 14 x 10 D53
Enalapril Tablet (Scored) 2.5 mg S 10 x 10 D197
5 mg 10 x 10 D198
Hydrochlorothiazide Tablet (Scored) 25 mg P 10 x 10 D259
Tablet 50 mg 10 x 10 D260
Hydrochlorothiazide Tablet 12.5mg P 10 x 10 D260A
Methyldopa Tablet (Film Coated) 250 mg S 10 x 10 D337
Nifedipine Capsule 5 mg P 10 x 10 D366
Tablet (Sustained 10 mg 10 x 10 D367
Released)
20 mg 10 x 10 D368
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Betamethasone Ointment/Cream 0.1% (as vale rate) P 15gm tube D73
Hydrocortisone Acetate Ointment or Cream 1% (as vale rate) P 15gm tube D262
Clotrimazole Betamethasone Cream 5 gm P 5gmtube D590
+ Neomycine Sulphate
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ivermectin Tablet (Scored) 6mg T 1 tab x 10 D296
Permethrin Cream 5% P 30g D714
Lotion 1% U 50ml D715
Fusidic Acid Cream 2% P 10g D645
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Hydrocortisone Acetate Suppository; Retention 25 mg S D263
Enema
Sulphasalazine Tablet 500 mg S 10 x 10 D493
20.4 Antispasmodic medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Dicyclomine Hydrochloride Tablet 10mg P 10 x 10 D172
Injection 10mg/ml 2ml ampoule D173
Hyosine Butyl Bromide Tablet 10mg P 10 x 10 D269
suppository 20mg/ml D270
Drotavarine Injection 20mg/ml S 2ml D618
Tablet 40mg 10x10 D619
20.5 Laxatives
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Bisacodyl Tablet 5mg P 10 x 10 D78
Suppository 10mg S 1x5 pkt D570
Lactulose Syrup 667mg/ml S 60ml D550
Glycerine Sodium Chloride Enema 15 % w/v 30ml, P 20mlplasticampoule D652
21.3 Estrogens
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Estradiol Valerate Tablet 2mg S 10 x 10 D207
Conjugated Equine Oestrogen Tablet 0.625mg T 10 x 10 D139
10mg 10 x 10 D327
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
BCG Vaccine Injection U Vial D65
Diphtheria,Pertussis and Injection U Vial D186
Tetanus combined (DPT)
vaccine
Hepatitis B Vaccine Injection 20mcg U 1ml Vial D257
Measles Vaccine Injection U Vial D323
Poliomyelitis Vaccine Oral Drop U D417
Tetanus Vaccine (Tetanus Injection U 5ml ampoule D499
Toxoid)
MMR (Live Vaccine) Injection P D357
22.3.2 For specific groups of individuals
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Anti rabies Vaccine Injection IM administration 2.5 IU S Vial D42
(Chickembryo)
Typhoid Vaccine Injection T Vial D759
Pneumococcal Injection T Vial D716
Hib vaccine Injection T Vial D658
23. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Neostigmine Metilsulfate Injection 500 micrograms S 1ml ampoule D361
2.5 mg 5ml ampoule D362
Suxamethonium Chloride Powder for Injection 50 mg/ml S Vial D495
(Succinylchloline)
Pancuronium Injection 2mg/ml T 10ml vial D394
Vecuronium Powder for Injection 20mg T Vial D519
Atracurium Injection 10mg/ml T 2.5ml ampoule D54
Tamsulosin Tablet 0.4mg T(R) a ND29
24. SPECIFIC MEDICINES FOR NEONATAL CARE
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Epinephrine Hydrochloride Injection 1 mg/ml P 1ml ampoule D199
(Adrenaline)
Atropine Sulphate Injection 0.6 mg/ml S 2ml ampoule D56
Sodium bi Carbonate Injectable Solution 1.4% Isotonic S D475
(Intravenous Fluid) (equivalent to Na+
167 mmol/l, HCO3-
167 mmol/l)
Calcium Gluconate Injection 100 mg/ml S 10ml ampoule D84
Dextrose Injectable Solution 10% Isotonic P 250ml/ 500ml D159
(Intravenous Fluid)
Salbutamol Sulphate Syrup 2 mg/5 ml P 100 ml D463
Respirator Solution for use 5 mg/ml 15ml D465
in Nebulizers
Sucrose Solution 24% T 10mlAmpoule D739
Surfactant porcine Injection 4ml/kg T(R) Vail D741
Caffein Citrate Injection 20mg/ml T 3mlvial D574
Syrup 20mg/ml 3ml vial D575
Indomethacin Injection 1mg T Vial D669
25. OPHTHALMOLOGICAL PREPARATIONS
25.1 Anti-infective agents
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Gentamicin Sulphate Solution (Eye/Ear drop) 0.30% P 5ml D244
Ciprofloxacin Hydrochoride Solution (Eye/Ear Drop) 0.3% w/v sterile P S 5ml D125
aqueous
Ointment (Eye/Ear) 0.30% 5gm Tube D126
Miconazole Solution (Eye Drop) 1% P 10ml D348
Povidone Iodine Ointment/ Drop 0.60% S D424
Acyclovir Ophthalmic Ointment 3.00% S 5gm tube D9
Ofloxacin Eye drops solution 0.30% P 5ml D551
Tobramycine Eye drops solution 0.30% P 5ml D552
Fluorescein Sodium Strip S D229
Tropicamide Eye Drops Solution 0.50% S 5ml drops D512
Moxifloxacin Eye drops solution 0.5%v/w S 5 ml vial D695
Fluconazole Eye drops solution 0.30% S 5 ml vial D636
Natamycin Eye drops solution 5% T 5 ml vial D697
25.2 Anti-inflammatory agents a
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Prednisolone Sodium Solution (Eye Drop) 0.50% S 5ml D430
Phosphate
1% 5ml D719
Dexamethasone Eye drops solution 0.10% S 5ml D606
Fluoromethalone acetate Eye drops solution 0.10% T 5ml D638
Ketorolac tromethamine Eye drops solution 1% S 5ml D677
Flurbiprofen Eye drops solution 0.03% S 5ml D641
25.3 Local anaesthetics see as per section 1.2
25.4 Miotics and antiglaucoma medicines
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Acetazolamide Tablet 250 mg S 10 x 10 D1
Pilocarpine Hydrochloride or Solution (Eye Drop) 2.00% S 5ml D412
Nitrate
4.00% 5ml D413
25.5 Mydriatics
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Homatropine Solution (Eye Drop) 2% P 5ml D258
Phenylephrine Solution (Eye Drop) 4.00% P 5ml D407
Atropine Sulphate Solution (Eye Drop) 1.00% S 5ml D59
Eye ointment 1% P 3gm Tube D542
Tropicamide+Phenylephrine Eye drops solution 0.8%+5% T 5ml D758
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Imipramine Hydrochloride Tablet 25 mg P 10 x 10 D275
Fluoxetine Hydrochloride (for Tablet 20mg T 10 x 10 D230
use above 8 years of age)
400 mg 10 x 10 D87
500mg 10 x 10 D515
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Diazepam Tablet (Scored) 5 mg P 10 x 10 D165
Triclofos Syrup 500mg/5ml T 30 ml D757
Chlordiasopoxide Tablet 25mg S 10x10 D585
Clonazepam Tablet 0.5mg P 10x10 D588
29.2 Parenteral
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Dextrose Injectable Solution 5% P 250ml/500ml D158
(Intravenous Fluid)
10% Isotonic 250ml/500ml D159
Magnesium Chloride
0.031gm
29.3 Miscellaneous
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Water for injection Injection P 2ml ampoule D532
5ml ampoule D533
10ml ampoule D534
sodium citrate Syrup 100ml S ND1
30. VITAMINS AND MINERALS
Name of Drug Formulation Strength/Size Facility code Unit Packs EDL Code
Ascorbic Acid (Vit C) Tablet (Scored) 100 mg P 10 x 10 D51
Ascorbic Acid (Vit C) Tablet (Scored) 500 mg P 10 x 10 D51A
Iodine Solution 8mg/5ml S D280
Folic Acid Tablet 1mg S 10 x 10 D232
5mg 10 x 10 D233
Vitamin A Palmitate Tablet 50 000 IU P 10 x 10 D524
Oral Oily Solution 100 000 IU/ml U Multidose Dispenser D525
Thiamine Hydrochloride (Vit Injection 50mg S 10ml D502
B1)
Riboflavin (Vit B2) Tablet 5mg U 10 x 10 D455
Pyridoxine Hydrochloride (Vit Tablet 25 mg P 10 x 10 D447
B6)
Multivitamin (B1,B2,B6, Tablet/ Capsule 10mg + 10mg + 3mg P 10 x 10 D63
Niacinamide, Pantothenate, + 100mg + 50mg +
Folic Acid, Ascorbic Acid, 1.5mg + 150mg +
Biotin) 100mcg
Vitamin B12 (Cyanocobalamin) Injection 500mcg/ml S 5ml ampoule D526
16 Nos S C126
Trochar and canula bivalve (Disposable
18 Nos S C127
and Metallic) (For SPC)
20 S C128
3/0 6 Reels T S2
B.B. silk with 3/8 Cir CD with cutting
needle 45mm length 76cm
8/0 6 Reels T S84
2 6 Reels S S8
Black braided silk (without needle in reels)
2/0 6 Reels S S9
Polyglecapron with 3/8 cir cutting needle 25mm 3/0 12 Foils T S49
Therapeutic Class
References
Proposed Drug
Drug available in
existing EDL
Safety: This column should summarise the possible side effects. If possible, the
incidence of frequent side effects and safety margins should be listed.
Cost Effectiveness: Total cost of the treatment rather than cost per unit should be the
guiding factor.
Submitted by :
Address:
Contact Person:
Telephone Number:
Signature: Date:
SUSPECTED ADVERSE DRUG REACTION REPORTING FORM
For VOLUNTARY reporting of Adverse Drug Reactions by healthcare professionals
B. SUSPECTED ADVERSE REACTION 13. Other relevant history including pre-existing medical
conditions (e.g. allergies, race, pregnancy, smoking, alcohol
5. Date of reaction started (dd/mm/yyyy)
use, hepatic/ renal dysfunction etc)
6. Date of recovery (dd/mm/yyyy)
7. Describe reaction or problem
15. Outcomes
Fatal Recovering Unknown
Continuing Recovered Other (specify)
H
C. SUSPECTED MEDICATION(S)
S.No 8. Name Manufact Batch Exp. Date Dose Route Frequency Therapy dates (if known, Reason for use of
(brand and urer No./ Lot (if known)) used used give duration) prescribed for
/or generic (if known) No. Date Date
name) (if known) started stopped
i.
ii.
iii.
iv.
S.No 9. Reaction abated after drug stopped or dose 10. Reaction reappeared after reintroduction
As per C reduced
Yes No Unknown NA Reduced dose Yes No Unknown NA If reintroduced dose
i.
ii.
iii.
iv.
11. Concomitant medical product including self D. REPORTER (see confidentiality section on first page)
medication and herbal remedies with therapy dates 16. Name and Professional Address :_
(exclude those used to treat reaction)
Pin code: E-mail _________
Tel. No. (with STD code): _________
Occupation Signature _________________